Humanscape to Build the Finest Blockchain-based Patient Network in Asia

Food and Healthcare Press Releases Thursday August 2, 2018 15:03
SEOUL, South Korea--2 Aug--PRNewswire/InfoQuest
  • Direct sharing of symptoms and treatment processes and provision of compensation for the sharing of information.
  • Expected to release blockchain-based "Humanscape" later this year.

Today, more and more people are suffering from serious, incurable, and/or rare illnesses. However, access to information on such conditions has been quite limited, to hospitals or internet surfing. Even though there were communities and organizations serving people with certain illnesses, information was not widely available, due to the general nature of the illnesses.

Min-hoo Chang, the CEO of Humanscape, giving a speech at 'Blockchain Expo 2018' held in Amsterdam

Developing and implementing IT solutions in the healthcare sector for the past four years, Humanscape realized that there is a lack of proper health information platforms. They believed that providing an information exchange platform that gives patients complete control over their patients-generated health data (PGHD) and allowing pharmaceutical companies, doctors, and hospitals to utilize the data, will help us find new treatments and further improve existing treatments.

In addition, applying blockchain technology to such patient health data management will enable safe data exchange and storage. When patients record information on their illnesses via Humanscape, the information is encrypted and can only be used in designated areas. Additionally, patients will be compensated accordingly when they share information on the patient's platform. Min-hoo Chang, CEO of Humanscape, commented, "Since the simple act of sharing information can be so helpful for people suffering from rare and incurable diseases, we expect to see a high participation rate." Patients can exchange their compensation for cash. Humanscape Team is also planning on having various dApps (decentralized apps) to allow patients to purchase non-prescription, functional foods and medical equipment with its own currency earned as compensation.

The welcoming responses of patient organizations and pharmaceutical companies towards Humanscape exceeded its expectations. Chang commented, "Patient organizations that were in dire need of well-structured patients data have come to recognize the value of the Humanscape Project. Humanscape has signed MOUs with patient organizations for rare retina-related diseases, Korean Foundation Fighting Blindness and Amseungmo (one of the most well-known cancer patient communities), and is also discussing multi-faceted cooperation with many more." Chang also mentioned that, "Executives of global pharmaceutical companies that needed patient information on patients' medication, physical condition, and lifestyle, have joined Humanscape as advisors and are actively involved in the company's business activities."

Humanscape's long-term goal is to provide the best healthcare community service in Asia, especially in countries with poor medical services. To this end, the company has established a subsidiary in Indonesia and is currently establishing partnerships with local companies and hospitals. Furthermore, Humanscape is entering the Vietnamese market through the Ministry of SMEs and Startups' Global Expansion Program (GEP) with the support of the Chungnam Center for Creative Economy and Innovation.

Chang said, "There are relatively few patients with rare and incurable diseases, which makes it difficult for pharmaceutical companies to be active in this field. However, if a proper medicine is to be developed, it would be a blue ocean. In this context, if we are able to achieve our goal of creating the best patient community in Asia, I am certain that it will be beneficial to all."

Photo -
Caption: Min-hoo Chang, the CEO of Humanscape, giving a speech at 'Blockchain Expo 2018' held in Amsterdam

Latest Press Release

Brain Health Supplements Market Expecting an Outstanding Growth Till 2025

The global brain health supplements market size is expected to reach USD 10.7 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.2% over the forecast period. Growing health concerns over depression, anxiety,...

Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced that it will launch the new VRNxT(TM), a volume reduction instrument optimized to remove manual sample volume reduction steps in cellular biology...


The "6 months mother's milk is all you need" campaign has been awarded South East Asia PR Campaign of the year and Cause related public awareness campaign of the Year by Campaign Asia at the PR awards in Hong Kong last month. Initiated by Save The...

Daewoong Pharmaceutical participated in the IMCAS Asia 2019 to introduce the excellence of NABOTA

Daewoong Pharmaceutical Co., Ltd, a world-leading botulinum toxin manufacturer in Korea, announced its participation in IMCAS Asia 2019 held in Bali, Indonesia July 5-7, 2019 to introduce the excellence of NABOTA(R) (Prabotulinumtoxin A). The 13th year...

ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia

The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch of Gene Therapy in Hemophilia: An ISTH Education Initiative. This landmark launch, the first of its kind in hemophilia, will take place during the...

Related Topics